[Antibiotic prophylaxis in digestive tract and abdominal wall surgery]
Plante É
Record ID 32018014849
French
Original Title:
Antibioprophylaxie lors de chirurgies du tractus digestif et de la paroi abdominale
Authors' objectives:
Surgical site infections (SSIs) are a common complication following surgery and are
associated with increased morbidity and high costs for the healthcare system. Among the
available prevention strategies, antibiotic prophylaxis—when properly applied—plays a
key role in reducing these infections. In Québec, where the fight against antibiotic
resistance and the prevention of nosocomial infections are priorities, this work is part of
the Institute’s commitment to making recommendations that are up to date and consistent
with the latest scientific data and trends in best practices, particularly in antibiotic
stewardship. It seeks to equip healthcare professionals and harmonize clinical practices
in antibiotic prophylaxis for surgical procedures involving the digestive tract and
abdominal wall.
Authors' results and conclusions:
RESULTS (#1 TREATMENT PRINCIPLES THAT OPTIMIZE THE EFFECTIVENESS OF SSI PREVENTION): To maximize its effectiveness, antibiotic prophylaxis relies on both the judicious
choice of antibiotic and strict adherence to administration timing, which are
determining factors in ensuring its preventive effect. (#2 TARGETED ANTIBIOTIC PROPHYLAXIS TO MEET REAL SSI PREVENTION NEEDS WHILE LIMITING
ANTIBIOTIC OVERUSE): Antibiotic prophylaxis is not recommended for esophageal and gastroduodenal
surgeries without entry into the lumen, low-risk cholecystectomies, proctological
surgeries and low-risk hernia repairs. (#3 ADDING ORAL ANTIBIOTIC PROPHYLAXIS IN COLORECTAL SURGERY TO MAXIMIZE SSI PREVENTION): • As a complement to intravenous antibiotic prophylaxis, adding oral antibiotic
prophylaxis combined with mechanical bowel preparation the day before
colorectal surgery can significantly reduce SSI.
• However, limited access to oral neomycin in Quebec, which is only available
through compounding, is a potential issue that may limit its use. CONCLUSION: The optimal use guide provides clear recommendations tailored to the clinical context
and seeks to optimize the use of antibiotic prophylaxis in general surgery involving the
digestive tract and abdominal wall. These recommendations aim to improve SSI
prevention while promoting the optimal use of antibiotics. However, the potential impact
of these recommendations will depend on the dissemination of the guide accompanying
this report and on the adoption of the clinical information and recommendations by
healthcare professionals. In this regard, various avenues are suggested to support the
recommendations’ implementation in practice.
Authors' recommendations:
Triangulating information sources played a central role in critically evaluating and
updating the recommendations included in this work. These recommendations are
included in sidebars throughout the report and have been incorporated into the optimal
use guide, the clinical resource that resulted from this work.
Authors' methods:
A systematic review of the literature on best clinical practices in antibiotic prophylaxis in
digestive tract and abdominal wall surgery was conducted according to INESSS’s
methodological standards. This exercise was supplemented by an analysis of recent
systematic reviews focusing specifically on oral antibiotic prophylaxis in colorectal
surgery. The recommendations are the result of a rigorous and iterative process,
conducted in collaboration with a multidisciplinary advisory committee, that sought to
combine scientific, experiential and contextual data in a structured manner. The scientific
quality, relevance and applicability of the work were also validated by external readers
who are specialists in the field.
Authors' identified further research:
The utility of updating the recommendations will be assessed four years from the date of
publication of this guide based on advances in scientific data and changes in clinical
practices, the inscription of new drugs on the lists or significant changes to the public
drug insurance plan’s reimbursement criteria, along with the needs of the health and
social services network.
Details
Project Status:
Completed
Year Published:
2025
URL for published report:
https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Usage_optimal/ATBprophylaxie_chirurgie_tractus_abdominale_GN_INESSS.pdf
English language abstract:
An English language summary is available
Publication Type:
Other
Country:
Canada
Province:
Quebec
MeSH Terms
- Surgical Wound Infection
- Antibiotic Prophylaxis
- Neomycin
- Colorectal Surgery
- Surgical Procedures, Colorectal
- Anti-Bacterial Agents
- Staphylococcus aureus
- Nasal Lavage
- Cefazolin
- Digestive System Surgical Procedures
Contact
Organisation Name:
Institut national d'excellence en sante et en services sociaux
Contact Address:
L'Institut national d'excellence en sante et en services sociaux (INESSS) , 2021, avenue Union, bureau 10.083, Montreal, Quebec, Canada, H3A 2S9;Tel: 1+514-873-2563, Fax: 1+514-873-1369
Contact Name:
demande@inesss.qc.ca
Contact Email:
demande@inesss.qc.ca
Copyright:
L'Institut national d'excellence en sante et en services sociaux (INESSS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.